BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18229415)

  • 1. Aspirin dose do's and don'ts.
    Johns Hopkins Med Lett Health After 50; 2007 Oct; 19(8):1-2. PubMed ID: 18229415
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin: expectations and limitations.
    Rao GH
    J Assoc Physicians India; 2008 May; 56():317-9. PubMed ID: 18700637
    [No Abstract]   [Full Text] [Related]  

  • 3. Enteric coated aspirin.
    Grossman CM
    Am J Med; 2007 Apr; 120(4):e9. PubMed ID: 17398216
    [No Abstract]   [Full Text] [Related]  

  • 4. Is enteric aspirin safer than regular aspirin?
    Johns Hopkins Med Lett Health After 50; 2013 Aug; 25(7):7. PubMed ID: 24386685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Withdrawing the use of acetylsalicyclic acid prior to an operation usually not necessary].
    van den Broek JA; van Duijnhoven JL
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):469; author reply 469. PubMed ID: 12666521
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acetylsalicylic acid and gastrointestinal hemorrhages: preferably a lower dosage].
    Tytgat GN; Vreeburg EM; van der Meer J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2219-23. PubMed ID: 8984364
    [No Abstract]   [Full Text] [Related]  

  • 7. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.
    Takada M; Fukumoto K; Shibakawa M
    J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose aspirin for the prevention of atherothrombosis.
    Patrono C; García Rodríguez LA; Landolfi R; Baigent C
    N Engl J Med; 2005 Dec; 353(22):2373-83. PubMed ID: 16319386
    [No Abstract]   [Full Text] [Related]  

  • 9. Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.
    Mardikar H; Deo D; Deshpande N; Mardikar M; Ghosh A; Munot K; Steinhubl S; Mukherjee D
    J Assoc Physicians India; 2008 May; 56():321-4. PubMed ID: 18700638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin revisited: helpful or harmful? What is the correct dose for a certain population?
    Drown DJ
    Prog Cardiovasc Nurs; 2008; 23(1):49-50. PubMed ID: 18326997
    [No Abstract]   [Full Text] [Related]  

  • 11. New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.
    Harv Heart Lett; 2009 Jun; 19(10):4-5. PubMed ID: 19681207
    [No Abstract]   [Full Text] [Related]  

  • 12. [Should warfarin and acetylsalicylic acid be withdrawn prior to tooth extraction?].
    Løkken P; Skjelbred P
    Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2498-9. PubMed ID: 16186871
    [No Abstract]   [Full Text] [Related]  

  • 13. Who should be taking aspirin?
    Harv Heart Lett; 2002 Apr; 12(8):3-5. PubMed ID: 11959516
    [No Abstract]   [Full Text] [Related]  

  • 14. The choice of aspirin dose for primary prevention of embolic complications of nonvalvular atrial fibrillation in elderly people.
    Jolobe OM
    J Am Geriatr Soc; 2009 Jan; 57(1):172-3. PubMed ID: 19170796
    [No Abstract]   [Full Text] [Related]  

  • 15. Bleeding complications related to aspirin dose.
    Laine L; McQuaid K
    Am J Cardiol; 2005 Oct; 96(7):1035-6. PubMed ID: 16188542
    [No Abstract]   [Full Text] [Related]  

  • 16. In brief: enteric-coated aspirin as an antiplatelet drug.
    Med Lett Drugs Ther; 2014 Apr; 56(1441):36. PubMed ID: 24759295
    [No Abstract]   [Full Text] [Related]  

  • 17. Who needs to be taking aspirin for cardiovascular protection? Studies conflict about the benefits for women.
    Harv Health Lett; 2007 Jun; 32(8):4-5. PubMed ID: 17639622
    [No Abstract]   [Full Text] [Related]  

  • 18. Rebound inflammation and the risk of ischemic stroke after discontinuation of aspirin therapy.
    Pijak MR
    Arch Neurol; 2006 Feb; 63(2):300-1; author reply 301. PubMed ID: 16476829
    [No Abstract]   [Full Text] [Related]  

  • 19. [Low-dose aspirin induced intestinal damage -including the influence of low-dose aspirin to existing lesions-].
    Shibata T; Kamano T; Hirata I
    Nihon Shokakibyo Gakkai Zasshi; 2010 Dec; 107(12):1910-5. PubMed ID: 21139359
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose enteric-coated aspirin as an antiplatelet preparation.
    McLeod LJ; Roberts MS; Seville PR
    Med J Aust; 1988 Feb; 148(4):207. PubMed ID: 3340049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.